PREVIOUS
✖
Digital and Molecular Surveillance
April 21 , 2020
1554 days
880
0
- The Central Drug Research Institute (CDRI) has signed a Memorandum of Understanding (MoU) with King George Medical University to sequence the strains of COVID-19 virus samples obtained from different patients.
- This is to be done under a “Digital and Molecular Surveillance”.
- Molecular surveillance is currently being used in HIV drug testing, foodborne infections and TB.
- The CDRI is working on repurposing of drugs to fight COVID-19.
- The repurposing of drugs is the fastest way to find solution to the virus rather than finding a new drug.
- Repurposing of drugs is a new strategy that investigates the existing drugs for therapeutic purposes.
Leave a Reply
Your Comment is awaiting moderation.